Search Results 2891-2900 of 25150 for oral

1. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   Patients who have known gastrointestinal (GI) disease or GI procedures which could interfere with the oral absorption or tolerance of alisertib are not ...

2. Hormone therapy: Four things a Mayo Clinic women's health specialist wants you to know

   Hormone therapy is a prescribed medication that can come in different forms, including patches, gels, sprays and oral medications. Those options may include ...

3. Publications - Harry E. Fuentes Bayne, M.D., M.S. - Mayo Clinic

   Oral Oncol. 2025 May 17; 166:107308 [Epub ahead of print] View PubMed; Yin LX, Hidalgo CM, Bogan AW, Hunter DE, Bartemes KR, Tasche KK, Moore EJ, Price DL ...

4. Kiaran P. McGee, Ph.D. - Doctors and Medical Staff - Mayo Clinic

   Oral ExaminerAmerican Board of Radiology. 2015 - 2018. MemberRadiologic Physics Oral Boards Examiner, American Board of Radiology. 2014 - 2017. MemberAmerican ...

5. Paget's disease of bone - Diagnosis & treatment - Mayo Clinic

   Oral bisphosphonates include: Alendronate (Fosamax, Binosto); Risedronate (Actonel, Atelvia). Rarely, bisphosphonate therapy has been linked to severe muscle ...

6. A Study to Evaluate Triapine Combined with Lutetium Lu 177 Dotatate for Gastroenteropancreatic Neuroendocrine Tumors - Mayo Clinic

   Patients with an inability to swallow oral medications or gastrointestinal disease limiting absorption of oral agents. Patients who have received prior ...

7. A Study to Examine Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia - Mayo Clinic

   Mucocutaneous telangiectasia at characteristic sites (lips, oral cavity, fingers or nose);; Organ AVM (lung, brain, liver, renal, spinal or limb AVMs or GI ...

8. A Study of Serum Baclofen Levels in Patients with Intrathecal Baclofen Therapy - Mayo Clinic

   Participation eligibility · Use of oral baclofen within the previous 3 days. · Targeted drug delivery device utilizing medications other than baclofen monotherapy ...

9. A Study of the Prevalence of the Oropharyngeal Human Papillomavirus in Partners of Patients with Oropharyngeal Squamous Cell Carcinoma - Mayo Clinic

   ... oral or throat HPV infection. It is also unknown if certain sexual behaviors increase the risk of oral HPV infection. Participation eligibility. Participant ...

10. Interstitial Lung Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive Fibrosing ...